Surgery Websites
Conte Lab »  People »  Surgical Residents »  Evan Werlin, M.D.
Evan C. Werlin, M.D.

Evan C. Werlin, M.D.

Resident (PGY-4)
General Surgery 

Contact Information

Open Popup
  • Brown University, Providence, Rhode Island, Sc. B., Biology, 2008
  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, M.D. 2013
  • Vascular surgery
  • Biotechnology

Evan C. Werlin, M.D. is general surgery resident working on several clinical and translational research projects in the Conte Lab:

  • Developing a novel means of delivering an endogenously-produced specialized pro-resolving mediator that will modulate the body's inflammatory response following vascular injury
  •  Developing a non-invasive vascular assay (test) to identify patients at high risk for cardiovascular morbidity and mortality following kidney transplantation, research at the intersection of vascular and transplant Surgery

Dr. Werlin was also the recipient of the "The Teaching Excellence Award for Cherished Housestaff (T.E.A.C.H.)" from the UCSF School of Medicine, one resident commenting that he "stands out to me as one of the most heartfelt and genuine residents at UCSF".

 

Resident shown in bold. Research Mentor(s) shown in color.
  1. Werlin EC, Kaushik S, Gasper WJ, Hoffman M, Reilly LM, Chuter TA, Hiramoto JS. Multibranched endovascular aortic aneurysm repair in patients with and without chronic aortic dissections. J Vasc Surg. 2019 Jul 18. View in PubMed
  2. Conte MS, Desai TA, Wu B, Schaller M, Werlin E. Pro-resolving lipid mediators in vascular disease. J Clin Invest. 2018 08 31; 128(9):3727-3735. View in PubMed
  3. Wu B, Werlin EC, Chen M, Mottola G, Chatterjee A, Lance KD, Bernards DA, Sansbury BE, Spite M, Desai TA, Conte MS. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model. J Vasc Surg. 2018 12; 68(6S):188S-200S.e4. View in PubMed
  4. Sims CA, Yuxia G, Singh K, Werlin EC, Reilly PM, Baur JA. Supplemental arginine vasopressin during the resuscitation of severe hemorrhagic shock preserves renal mitochondrial function. PLoS One. 2017; 12(10):e0186339. View in PubMed
  5. Karamercan MA, Weiss SL, Villarroel JP, Guan Y, Werlin E, Figueredo R, Becker LB, Sims C. Can peripheral blood mononuclear cells be used as a proxy for mitochondrial dysfunction in vital organs during hemorrhagic shock and resuscitation? Shock. 2013 Dec; 40(6):476-84. View in PubMed
  6. Villarroel JP, Guan Y, Werlin E, Selak MA, Becker LB, Sims CA. Hemorrhagic shock and resuscitation are associated with peripheral blood mononuclear cell mitochondrial dysfunction and immunosuppression. J Trauma Acute Care Surg. 2013 Jul; 75(1):24-31. View in PubMed
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Evan C. Werlin, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

 

Site Directory
    X